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Literature Review 
 
• 2 million adults in the United States are dependent on heroin or non-medically 
prescribed prescription opioids (SAMHSA, 2006). 
• Opioid dependency has significant costs to society; $2.6 billion in health care 
costs annually, $1.4 billion in the criminal justice system; $4.6 billion to workplace 
(Journal of Clinical Pain, 2006). 
• Opioid dependence is a chronic and severe disorder associated with a 
substantial risk of mortality, and other psychiatric morbidity, as well as adverse 
social, vocational, familial, and legal consequences (Galanter & Kelber, 2008). 
• Analyses show that there is significant variations in the availability of evidence-
based practice substance abuse for opioid dependent clients (Doran, 2008). 
• Medication-assisted treatment is an evidence-based practice for opioid addiction 
(SAMHSA, 2006). 
• Medication-assisted treatment (MAT) is the use of  agonistic and/or antagonistic 
medications such as buprenorphine, suboxone, methadone, or naltrexone in 
combination with counseling and recovery support services (SAMHSA TIP 43, 
2005). 
• Despite research which supports medication-assisted substance abuse 
treatment is cost effective (Doran, 2008) and is an evidence-based practice for 
treatment for opioid dependence (SAMHSA, 2006) the implementation of these 
practices has yet to evolve in some rural communities. 
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Conclusions & Recommendations 
 
Gaps in Service Delivery Include: 
1.  Physician with prescribing privileges. 
2. Screening tools not adequately being used. 
3. Clients being referred to detoxification program and not MAT. 
4. Clients are not able to receive MAT in their own community. 
Recommendations 
Key stakeholders work towards the development of implementing 
evidence-based practices. Key stakeholders meet on a quarterly 
basis to develop workflow plan for the development of MAT 
program. 
 
Benefits to Agency 
Dual Recovery Program will be able to continue the development of 
an MAT program within their agency. 
	  
Project Methodology 
 
1. Identification of evidence-based practices for the treatment of 
individuals diagnosed with opioid dependence. 
2. Development of training on evidence-based practices for opioid 
dependence. 
3. Training provided for mental health professionals, case 
managers, substance abuse treatment providers, criminal justice 
system workers, social services providers, chemical health 
assessors, and other community members. 
4. Development and implementation of training for Primary Care 
Physicians at Mayo Clinic Health Systems–Owatonna Clinic. 
5. Meeting with Allina Health–Owatonna Hospital to develop 
Emergency Department response to opioid dependency. 
6. Identification of key stakeholders who can assist with the 
development and implementation of evidence-based        practices 
for opioid dependence. 
7. Identification of gaps in the service delivery area. 
8. Memorandum of  Agreement presented for signature to work 
towards the implementation of evidence-based practices in 
Owatonna Minnesota and the surrounding communities. 
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References are available from the author upon request. 
Statement of Purpose 
The purpose of this capstone project is to begin the implementation 
of evidence-based practices for opioid substance abuse population 
in the rural community of Owatonna, MN and the surrounding 
communities. 
 
 
B. Substance abuse treatment involves psychological and psychosocial interventions 
intended to reduce harmful substance abuse.  
•  Theories can include the following: 12 Step Facilitation, Cognitive-Behavioral 
Therapy, Contingency Management, Community Reinforcement.   
•  Treatment Modalities include: Inpatient Treatment, Outpatient Treatment, Partial 
Hospitalizations. 
•  Drug free treatment  
•  Very few studies have reported treatment outcomes for opioid abusers enrolled in 
drug-free outpatient treatment.   
•  We need to continue the evolution and evaluation of all forms of treatment.  
 
 Table 1:  Admissions to Substance Abuse 
Treatment Programs for Opioid Dependence 
has Increased in Minnesota in the Last Ten 
Years 
Table 3: Opioid Abusers have increased Health 
Costs Compared to Non-opioid Abusers 
 
Source: R. Moldenhauer, Minnesota State Opioid Treatment Authority (DAANE) 
Table 2: Admission to Substance Abuse 
Treatment Programs for Opioid 
Dependence has Increased Throughout 
the United States 
Source: Journal of Managed Care Pharmacy, (2005) 
Source: Journal of Clinic Pain, 2006 
 Current Modalities of Treatment 
 
  
 
 
A. Detoxification involves medically supervised withdrawal involving agonist and/or 
non-agonist medications.  Generally, detoxification is coupled with substance abuse 
treatment and/or psychosocial interventions.  Relapse rates for detoxification programs 
are high.  
 
 
 
 
 
 
 
 
 
 
 
 
 
In a British study with a 28 day hospital 
based detoxification program almost 75% 
of patients had relapsed at 6 months. 
This British study demonstrated how 
quickly opioid addicts relapsed after 
detoxification program.  After 6 weeks 
50% of patients relapsed. 
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C. Medication-assisted treatment (MAT) is the use of  agonistic and/or antagonistic 
medications such as buprenorphine, suboxone, methadone, or naltrexone in 
combination with counseling and recovery support services (SAMHSA TIP 43, 2005). 
  
• It is an evidence-based practice to treat adults with dual diagnoses of opioid 
dependence and a mental illness (SAMHSA, 2011). 
• MAT relapse rates are superior to detoxification programs.  In a one year study 
completed by Kakko, Svanberg, Kreek, and Helly (2003) clients who participated in 
Buprenorphine medication-assisted treatment program only 25% had relapsed after 
one year.  MAT relapse rates are superior to detoxification programs. 
• Retention rates in MAT treatment are greater than detoxification programs.  Mohan, 
Dhawan, Chopan, and Sethi (2006) found 81.5% of clients who participated in MAT 
program remained in treatment at 24 weeks.  
• MAT is a cost-effective intervention for treating opioid dependence.   Doran (2008) 
completed a review of 259 articles to determine cost effectiveness of MAT.  Doran 
found both the use of buprenorphine and methadone to be cost-effective. 
